Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies

Acute promyelocytic leukemia, a subtype of acute myeloid leukemia, is highly curable. In subgroup of patients with non-high-risk acute promyelocytic leukemia, intravenous arsenic trioxide plus all-trans-retinoic acid is considered the preferred regimen for acute promyelocytic leukemia. Recently, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasijareonrat, Natthaporn, Jahn, Nikolaus, Ungprasert, Patompong, Owattanapanich, Weerapat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318817/
https://www.ncbi.nlm.nih.gov/pubmed/32583728
http://dx.doi.org/10.1177/1533033820937008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318817/
https://www.ncbi.nlm.nih.gov/pubmed/32583728
http://dx.doi.org/10.1177/1533033820937008

Ejemplares similares